Results 61 to 70 of about 21,121 (265)

Drug substitutes − Insights on benefits, risks, detection methods, and management strategies: a systematic review

Frontiers in Psychiatry
The abuse of new psychoactive substances and narcotic drugs as drug substitutes poses a serious threat to public health and safety. This study outlines the effective use and negative abuse of drug substitutes and outlines associated criminal behaviors to
Song Bai, Song Bai, Miao Li, Shouying Tang, Suran Wan, Rong Wu, Lijun Chen, Fang Wang, Shan Liu, Shan Liu, Shan Liu   +10 more
doaj   +1 more source

Do national drug control laws ensure the availability of opioids for medical and scientific purposes?

Bulletin of the World Health Organization, 2014
Objective To determine whether national drug control laws ensure that opioid drugs are available for medical and scientific purposes, as intended by the 1972 Protocol amendment to the 1961 Single Convention on Narcotic Drugs.
S Asra Husain, Marty Skemp Brown, Martha A Maurer   +2 more
doaj   +1 more source

Change of substance‐related hospitalisation in adolescents after cannabis legalisation in Thailand in 2022

Addiction, EarlyView.
Abstract Background and aims On 9 June 2022, Thailand changed its cannabis legislation, expanding access to individuals aged >18 years. Evidence suggests that such changes could increase the risk of cannabis use and related harms, and could influence patterns of use of other substances among adolescents.
Sirada Puetpaiboon, Songyos Rajborirug, Vorthunju Nakhonsri, Chumpol Ngamphiw, Peerapat Khunkham, Sissades Tongsima, Watcharapot Janpoung, Virasakdi Chongsuvivatwong   +7 more
wiley   +1 more source

Extract from the Report of the 38th Expert Committee on Drug Dependence, convened from 14 to 18 November 2016, at WHO headquarters in Geneva.

, 2016
Agenda item 6 (b) Implementation of the international drug control treaties: changes in the scope of control of substances. Extract from the Report of the 38th Expert Committee on Drug Dependence: Substances recommended to be scheduled in Schedule I

core  

Association of Reduction in Continuity of Care During COVID‐19 Pandemic With Cardiovascular Diseases, Kidney Failure and All‐Cause Mortality for People With Diabetes: A Cohort Study in Hong Kong

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Introduction Continuity of care, a critical component of high‐quality primary care, was interrupted in people with diabetes mellitus during the COVID‐19 pandemic in Hong Kong. Research on whether reduced continuity of care was associated with higher complications and mortality risks is lacking.
Yuk Kam Yau, Meijiao Li, Jianchao Quan, Karen Ann Grépin, Gary Kui Kai Lau, Ivy Lynn Mak, Chak Sing Lau, Ian Chi Kei Wong, David Vai Kiong Chao, Welchie Wai Kit Ko, Cindy Lo Kuen Lam, Eric Yuk Fai Wan   +11 more
wiley   +1 more source

Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?

Bulletin of the World Health Organization
OBJECTIVE: The World Trade Organization's Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement establishes minimum standards for intellectual property rights, including patent protection for pharmaceuticals; therefore, it may make it ...
Maria Auxiliadora Oliveira, Jorge Antonio Zepeda Bermudez, Gabriela Costa Chaves, Germán Velásquez   +3 more
doaj   +1 more source

Analgesic effects of alpha‐2‐adrenoreceptor agonists in equine medicine: systemic, spinal, and local applications

Equine Veterinary Education, EarlyView.
Summary Alpha‐2‐adrenoreceptor agonists provide analgesia when used as sole agents but can also be used in combination with other drugs for their additive and potentially synergistic effects. Further, because of their effects on blood flow, alpha‐2‐adrenoreceptor agonists act to extend and perhaps intensify the effects of drugs, such as local ...
J. Brandly, J. R. Page, J. A. E. Hubbell, W. W. Muir III, K. Hopster   +4 more
wiley   +1 more source

Narcotic and psychotropic problems : international collaboration on health aspects / H. D. Archibald

, 1986
ONLINEWHO/NAPD86/WP4.
World Health Organization. Programme on Substance Abuse, Archibald, H. D, Conference of Ministers of Health on Narcotic and Psychotropic Drug Misuse (1986 : London, United Kingdom)   +2 more
core  

Physiological and behavioural effects of continuous remifentanil‐xylazine administration in donkeys

Equine Veterinary Journal, EarlyView.
Abstract Background Remifentanil and xylazine are used as continuous infusions to facilitate standing surgery in horses. Their use for this purpose has not been reported in donkeys. Objectives To evaluate the behavioural, sedative, and cardiorespiratory effects of continuous intravenous infusion of remifentanil and xylazine in donkeys. Study Design Non‐
Kássia Fernanda Araújo Damasceno, Andressa Nunes Mouta, Larissa de Sant' Ana Alves, Kathryn Nóbrega Arcoverde, Herbert Reis Aragão, Jerson Marques Cavalcante, Valéria Veras de Paula   +6 more
wiley   +1 more source

Antimicrobial resistance: a global response

Bulletin of the World Health Organization, 2002
Resistance to antimicrobial therapies reduces the effectiveness of these drugs, leading to increased morbidity, mortality, and health care expenditure.
Smith Richard D., Coast Joanna
doaj